Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The capital will fuel Botanic Healthcare’s aggressive expansion strategy, with the company aiming to grow by 400 per cent over the next 3 years
Botanic Healthcare, India’s leading nutraceutical company, has successfully raised Rs 250 Crores (approximately $30 million) in its latest funding round. The investment, structured as equity financing, was led by Stakeboat Capital. The round saw participation from co-investors – Abakkus Four2Eight Opportunities Fund and DS Group, one of Stakeboat Capital’s LP (Limited Partner), showcasing a strong partnership and shared vision for long-term value creation. This funding will enable Botanic Healthcare to consolidate its group entities and strengthen its presence in the rapidly growing global nutraceutical market.
The capital will fuel Botanic Healthcare’s aggressive expansion strategy, with the company aiming to grow by 400 per cent over the next 3 years. As part of its plans, Botanic will enhance its product portfolio and forge strategic partnerships, while boosting its R&D and clinical research capabilities through joint ventures and collaborations.
Botanic’s growth vision is further supported by investments in technology, innovation, and talent acquisition. The company is focused on building a robust R&D pipeline and hiring top-tier professionals across various departments, including research, development, production, quality assurance, and sales, to effectively scale its operations.
Gaurav Soni, Founder & Director, Botanic Healthcare said, “With this funding, we will expand our product offerings, strengthen our global footprint, and invest in cutting-edge research to meet the evolving needs of our customers.”
“As we move forward, this fundraise will fuel our next phase of growth, empowering us to reach new markets, build strategic partnerships, and create even greater value for our stakeholders,” he added.